Synthesis of Potential Anticancer 1-(1H-Indol-3-yl)isoquinolines by Silver Nitrate Mediated Tandem Reactions of 2-Alkynyl­benzaldehyde Azines and Indoles

Yun-Hui Zhao; Yueyang Luo; Yingli Zhu; Hang Wang; Hangbin Zhou; Hailong Tan; Zhihua Zhou; Yong-Cheng Ma; Wenlin Xie; Zilong Tang

doi:10.1055/s-0036-1591743

Synlett, Table of Contents

Synlett 2018; 29(06): 773-778
DOI: 10.1055/s-0036-1591743

letter

Synthesis of Potential Anticancer 1-(1H-Indol-3-yl)isoquinolines by Silver Nitrate Mediated Tandem Reactions of 2-Alkynylbenzaldehyde Azines and Indoles

Authors

Yun-Hui Zhao*

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China

^dHunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, Hunan University of Science and Technology, Xiangtan 411201, P. R. of China Email: zhao_yunhui@163.com
Yueyang Luo

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China
Yingli Zhu

^bClinical Pharmacology Laboratory, Zhengzhou University People’s Hospital, No. 7, Wei Wu Road, Zhengzhou, Henan, 450003, P. R. of China
Hang Wang

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China
Hangbin Zhou

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China
Hailong Tan

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China
Zhihua Zhou*

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China

^dHunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, Hunan University of Science and Technology, Xiangtan 411201, P. R. of China Email: zhao_yunhui@163.com
Yong-Cheng Ma*

^bClinical Pharmacology Laboratory, Zhengzhou University People’s Hospital, No. 7, Wei Wu Road, Zhengzhou, Henan, 450003, P. R. of China
Wenlin Xie

^aSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, P. R. of China

^dHunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, Hunan University of Science and Technology, Xiangtan 411201, P. R. of China Email: zhao_yunhui@163.com
Zilong Tang

^cKey Laboratory of Theoretical Chemistry and Molecular Simulation, Ministry of Education, P. R. of China

Abstract

All articles of this category

Abstract

Novel antitumor compounds featuring isoquinoline and indole moieties were synthesized by a silver nitrate promoted domino reaction involving intramolecular cyclization, nucleophilic addition of indole, and subsequent N–N bond cleavage. The transformation from readily available starting materials into an interesting class of indole-substituted isoquinolines was completed under mild conditions and by simple operations in moderate to good yields. The antitumor activity of these compounds in vitro was significantly greater than that of a reference compound, 5-fluorouracil. The products might serve as new lead compounds for drugs for the treatment of cancer.

Key words

bond cleavage - domino reaction - isoquinolines - indoles - silver nitrate - medicinal chemistry

Full Text

References

References and Notes
1 Sygusch J. Brisse F. Hanessia S. Kluepfel D. Tetrahedron Lett. 1974; 15: 4021

2a Scott JD. Williams RM. Chem. Rev. 2002; 102: 1669
2b Siengalewicz P. Rinner U. Mulzer J. Chem. Soc. Rev. 2008; 37: 2676
2c Pu J.-Y. Peng C. Tang M.-C. Zhang Y. Guo J.-P. Song L.-Q. Hua Q. Tang G.-L. Org. Lett. 2013; 15: 3674

3a Kawagishi F. Toma T. Inui T. Yokoshima S. Fukuyama T. J. Am. Chem. Soc. 2013; 135: 13684
3b Enomoto T. Yasui Y. Takemoto Y. J. Org. Chem. 2010; 75: 4876

4a Wu Y.-C. Liron M. Zhu J. J. Am. Chem. Soc. 2008; 130: 7148
4b Chiba H. Sakai Y. Ohara A. Oishi S. Fujii N. Ohno H. Chem. Eur. J. 2013; 19: 8875

5a Molinski TF. Dalisay DS. Lievens SL. Saludes JP. Nat. Rev. Drug Discovery 2009; 8: 69
5b Peng C. Pu J.-Y. Song L.-Q. Jian X.-H. Tang M.-C. Tang G.-L. Proc. Natl. Acad. Sci. U. S. A. 2012; 109: 8540

6 Lin H.-R. Abraham DJ. Bioorg. Med. Chem. Lett. 2006; 16: 4178

7a Verma AK. Bansal S. Singh J. Tiwari RK. Sankar VK. Tandon V. Chandra R. Bioorg. Med. Chem. 2006; 14: 6733
7b Aneja R. Vangapandu SN. Joshi HC. Bioorg. Med. Chem. 2006; 14: 8352
7c Bermejo A. Andreu I. Suvire F. Léonce S. Caignard DH. Renard P. Pierré A. Enriz RD. Cortes D. Cabedo N. J. Med. Chem. 2002; 45: 5058

8a Vásquez D. Rodríguez JA. Theoduloz C. Verrax J. Calderon PB. Valderrama JA. Bioorg. Med. Chem. Lett. 2009; 19: 5060
8b Valderrama JA. Ibacache JA. Arancibia V. Rodríguez J. Theoduloz C. Bioorg. Med. Chem. 2009; 17: 2894
8c Gomez-Monterrey I. Campiglia P. Grieco P. Diurno MV. Bolognese A. La Colla PL. Novellino E. Bioorg. Med. Chem. 2003; 11: 3769

9 Chen C. Zhu Y. Liu X. Lu Z. Xie Q. Ling N. J. Med. Chem. 2001; 44: 4001

10a Chrzanowska M. Rozwadowska MD. Chem. Rev. 2004; 104: 3341
10b Giri P. Kumar GS. Mini-Rev. Med. Chem. 2010; 10: 568

11a Nakamura I. Yamamoto Y. Chem. Rev. 2004; 104: 2127
11b Zeni G. Larock RC. Chem. Rev. 2004; 104: 2285
11c Uchiyama M. Furuyama T. Kobayashi M. Matsumoto Y. Tanaka K. J. Am. Chem. Soc. 2006; 128: 8404
11d Furuyama T. Yonehara M. Arimoto S. Kobayashi M. Matsumoto Y. Uchiyama M. Chem. Eur. J. 2008; 14: 10348
11e Seomoon D. Lee PH. J. Org. Chem. 2008; 73: 1165
11f Korivi RP. Wu W.-J. Cheng C.-H. Chem. Eur. J. 2010; 16: 282
11g Lee K. Kim H. Mo J. Lee PH. Chem. Asian J. 2011; 6: 2147
11h Shi L. Ji Y. Huang W. Zhou Y. Acta Chim. Sin. (Engl. Ed.) 2014; 72: 820

12a Vachhani DD. Mehta VP. Modha SG. Van Hecke K. VanMeervelt L. Van der Eycken EV. Adv. Synth. Catal. 2012; 354: 1593
12b Roesch KR. Larock RC. J. Org. Chem. 2002; 67: 86
12c Zhao Y.-H. Li Y. Guo T. Tang Z. Deng K. Zhao G. Synth. Commun. 2016; 46: 355
12d Zhao Y.-H. Li Y. Guo T. Tang Z. Xie W. Zhao G. Tetrahedron Lett. 2016; 57: 2257
12e Li Y. Zhao Y. Luo M. Tang Z. Cao C. Deng K. Youji Huaxue 2016; 36: 2504
12f Zhao Y.-H. Luo M. Li Y. Liu X. Tang Z. Deng K. Zhao G. Chin. J. Chem. 2016; 34: 857

13a Chen Z. Gao L. Ye S. Ding Q. Wu J. Chem. Commun. 2012; 48: 3975
13b Xiao Q. Sheng J. Ding Q. Wu J. Adv. Synth. Catal. 2013; 355: 2321

14a Chen Z. Yang X. Wu J. Chem. Commun. 2009; 45: 3469
14b Ren H. Ye S. Liu F. Wu J. Tetrahedron 2010; 66: 8242
14c Ye S. Yang X. Wu J. Chem. Commun. 2010; 46: 5238
14d Li S. Luo Y. Wu J. Org. Lett. 2011; 13: 4312
14e Qiu G. He Y. Wu J. Chem. Commun. 2012; 3836
14f Ye S. Liu G. Pu S. Wu J. Org. Lett. 2012; 14: 70

15a Dounay AB. Overman LE. Chem. Rev. 2003; 103: 2945
15b Lin H. Danishefsky SJ. Angew. Chem. Int. Ed. 2003; 42: 36
15c Galliford CV. Scheidt KA. Angew. Chem. Int. Ed. 2007; 46: 8748
15d Shen K. Liu X.-H. Lin L.-L. Feng X.-M. Chem. Sci. 2012; 3: 327

16a Yu X. Yang X. Wu J. Org. Biomol. Chem. 2009; 7: 4526
16b Yu X. Wu J. J. Comb. Chem. 2010; 12: 238

17a Zhao Y.-H. Li Y. Luo M. Tang Z. Deng K. Synlett 2016; 27: 2597
17b Ghavtadze N. Fröhlich R. Würthwein E.-U. Eur. J. Org. Chem. 2010; 1787

18 Song L. Gao D. Li S. Wang Y. Liu H. Jiang Y. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2017; 1063: 189
19 Zhao Y.-H. Li Y. Long Y. Zhou Z. Tang Z. Deng K. Zhang S. Tetrahedron Lett. 2017; 58: 1351
20 CCDC 1564922 contains the supplementary crystallographic data for compound 3a. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
21 1-(1H-Indol-3-yl)-3-phenylisoquinoline (3a); Typical Procedure AgNO₃ (50.7 mg, 0.3 mmol) and indole (2; 35.1 mg, 0.3 mmol) were added to a solution of 1,2-bis[2-(phenylethynyl)benzylidene]hydrazine (1a; 91.8 mg, 0.225 mmol) in DMSO (1.5 mL). The mixture was stirred at 80 °C until consumption of 1a was complete (TLC). The solid was removed by filtration, and the filtrate was diluted with H₂O (5 mL) and extracted with EtOAc (3 × 15 mL). The organic phases were combined, dried (Na₂SO₄), and concentrated under reduced pressure. The residue was subjected to column chromatography [silica gel, EtOAc–hexanes (1:5)] to give a light-brown solid; yield: 74.9 mg (78%); mp 234–236 °C. IR (KBr): 3162, 1619, 1551, 1492, 1400, 1242, 1135 cm^–1. ¹H NMR (500 MHz, DMSO-d₆ ,): δ = 11.74 (s, 1 H), 8.46 (d, J = 8.5 Hz, 1 H), 8.33–8.31 (m, 3 H), 8.09–8.01 (m, 3 H), 7.79 (t, J = 7.5 Hz, 1 H), 7.65 (t, J = 7.5 Hz, 1 H), 7.58–7.54 (m, 3 H), 7.45 (t, J = 7.5 Hz, 1 H), 7.24 (t, J = 7.5 Hz, 1 H), 7.17 (t, J = 7.5 Hz, 1 H). ¹³C NMR (125 MHz, DMSO-d₆ ): δ = 155.1, 148.8, 139.1, 137.7, 136.5, 130.2, 128.8, 128.5, 127.9, 127.7, 127.3, 127.1, 126.8, 126.5, 125.4, 121.9, 120.6, 120.0, 113.6, 111.8. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₃H₁₇N₂: 321.1392; found: 321.1396.

Supplementary Material

Supporting Information (PDF)

Synthesis of Potential Anticancer 1-(1H-Indol-3-yl)isoquinolines by Silver Nitrate Mediated Tandem Reactions of 2-Alkynyl­benzaldehyde Azines and Indoles

Authors

Synthesis of Potential Anticancer 1-(1H-Indol-3-yl)isoquinolines by Silver Nitrate Mediated Tandem Reactions of 2-Alkynylbenzaldehyde Azines and Indoles